Opening Day: Inhibikase Falls Below IPO Price In First Trading Day
December 27, 2020 at 14:11 PM EST
Shares of Inhibikase Therapeutics rose as much as 18% on Wednesday, but finished the day 10 cents below the stock's $10 IPO price. Inhibikase was scheduled to trade last month, but delayed the deal.
